EMEA-001124-PIP01-10-M04
Key facts
| Invented name |
Lojuxta
|
| Active substance |
Lomitapide
|
| Therapeutic area |
Other
|
| Decision number |
P/0332/2019
|
| PIP number |
EMEA-001124-PIP01-10-M04
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of (heterozygous or homozygous) familial hypercholesterolaemia
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Amryt Pharmaceuticals DAC
Tel. +44 1604 549 952 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|